Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank31
3Y CAGR-52.1%
5Y CAGR-17.9%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-52.1%/yr
vs +82.4%/yr prior
5Y CAGR
-17.9%/yr
Recent deceleration
Acceleration
-134.5pp
Decelerating
Percentile
P31
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $17.91M | -76.9% |
| 2023 | $77.61M | +220.8% |
| 2022 | $24.19M | -85.1% |
| 2021 | $162.64M | +193.6% |
| 2020 | $55.39M | +15.1% |
| 2019 | $48.12M | -4.6% |
| 2018 | $50.42M | +243.5% |
| 2017 | $14.68M | -42.1% |
| 2016 | $25.34M | -29.8% |
| 2015 | $36.08M | - |